These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6791220)

  • 1. Facilitation of shock-induced fighting following intraventricular 5,7-dihydroxytryptamine and 6-hydroxydopa.
    Kantak KM; Hegstrand LR; Eichelman B
    Psychopharmacology (Berl); 1981; 74(2):157-60. PubMed ID: 6791220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracortical 5,7-dihydroxytryptamine depletes brain serotonin concentrations without affecting spontaneous activity.
    Black RS; Robinson RG
    Pharmacol Biochem Behav; 1985 Feb; 22(2):327-31. PubMed ID: 3983223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5,7-dihydroxytryptamine-induced mouse killing and behavioral reversal with ventricular administration of serotonin in rats.
    Applegate CD
    Behav Neural Biol; 1980 Oct; 30(2):178-90. PubMed ID: 7192550
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of adult or neonatal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine on locomotor activity, monoamine levels, and response to caffeine.
    Erinoff L; Snodgrass SR
    Pharmacol Biochem Behav; 1986 Apr; 24(4):1039-45. PubMed ID: 3086901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased tilt-cage activity after serotonin depletion by 5,7-dihydroxytryptamine.
    Mackenzie RG; Hoebel BG; Norelli HC; Trulson ME
    Neuropharmacology; 1978 Nov; 17(11):957-63. PubMed ID: 152872
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemical and behavioral alterations in developing rats treated with 5,7-dihydroxytryptamine.
    Breese GR; Vogel RA; Mueller RA
    J Pharmacol Exp Ther; 1978 Jun; 205(3):587-95. PubMed ID: 307057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 5,6-dihydroxytryptamine and 5,7-dihydroxytryptamine on the rat central nervous system after intraventricular or intracerebral application and on blood platelets in vitro.
    Da Prada M; Pieri L; Keller HH; Pieri M; Bonetti EP
    Ann N Y Acad Sci; 1978 Jun; 305():595-620. PubMed ID: 152083
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of intraventricular injection of 5,7-dihydroxytryptamine on serum gonadotropins and prolactin.
    Wuttke W; Hancke JL; Höhn KG; Baumgarten HG
    Ann N Y Acad Sci; 1978 Jun; 305():423-36. PubMed ID: 280254
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhancement of footshock-induced analgesia by spinal 5,7-dihydroxytryptamine lesions.
    Hutson PH; Tricklebank MD; Curzon G
    Brain Res; 1982 Apr; 237(2):367-72. PubMed ID: 7083000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-Hydroxydopa depletion of brain norepinephrine and the function of aggressive behavior.
    Thoa NB; Eichelman B; Richardson JS; Jacobowitz D
    Science; 1972 Oct; 178(4056):75-7. PubMed ID: 4672239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin-lesion myoclonic syndromes. I. Neurochemical profile and S-1 receptor binding.
    Pranzatelli MR; Rubin G; Snodgrass SR
    Brain Res; 1986 Jan; 364(1):57-66. PubMed ID: 3484992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal administration of 5,6-DHT or 5,7-DHT reduces morphine and substance P-antinociceptive activity in the rat.
    Rodríguez FD; Rodríguez RE
    Neuropeptides; 1989; 13(2):139-46. PubMed ID: 2472573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats.
    Nabeshima T; Yamaguchi K; Ishikawa K; Furukawa H; Kameyama T
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1139-46. PubMed ID: 2826756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal motility and body weight gain in rats after brain serotonin depletion by 5, 7-dihydroxytryptamine.
    Saller CF; Stricker EM
    Neuropharmacology; 1978 Jul; 17(7):499-506. PubMed ID: 692815
    [No Abstract]   [Full Text] [Related]  

  • 15. Tonic convulsive thresholds and responses during the postnatal development of rats administered 6-hydroxydopamine or 5,7-dihydroxytryptamine within three days following birth.
    Waller SB; Buterbaugh GG
    Pharmacol Biochem Behav; 1983 Dec; 19(6):973-8. PubMed ID: 6419239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hypothalamic injections of 5,7-dihydroxytryptamine on elicitation of mouse-killing in rats.
    Vergnes M; Kempf E
    Behav Brain Res; 1982 Aug; 5(4):387-97. PubMed ID: 6889881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 5,7-dihydroxytryptamine on the development of tolerance to ethanol.
    Lê AD; Khanna JM; Kalant H; LeBlanc AE
    Psychopharmacology (Berl); 1980 Feb; 67(2):143-6. PubMed ID: 6768090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5,7-DHT-induced muricide: inhibition as a result of preoperative exposure of rats to mice.
    Marks PC; O'Brien M; Paxinos G
    Brain Res; 1977 Oct; 135(2):383-8. PubMed ID: 562701
    [No Abstract]   [Full Text] [Related]  

  • 19. 5,7-Dihydroxytryptamine lesions of the ascending 5-hydroxytryptamine pathways: habituation, motor activity and agonistic behavior.
    Hole K; Johnson GE; Berge OG
    Pharmacol Biochem Behav; 1977 Sep; 7(3):205-10. PubMed ID: 563078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric action of intraventricular monoamine neurotoxins.
    Gershanik OS; Heikkila RE; Duvoisin RC
    Brain Res; 1979 Oct; 174(2):345-50. PubMed ID: 487133
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.